表紙:酸化ストレスアッセイの世界市場(2021年~2028年)
市場調査レポート
商品コード
1063204

酸化ストレスアッセイの世界市場(2021年~2028年)

Global Oxidative Stress Assay Market - 2021-2028

出版日: | 発行: DataM Intelligence | ページ情報: 英文 170 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
酸化ストレスアッセイの世界市場(2021年~2028年)
出版日: 2022年03月03日
発行: DataM Intelligence
ページ情報: 英文 170 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の酸化ストレスアッセイ市場について調査分析し、市場力学、業界分析、市場分析、競合情勢など、体系的な情報を提供しています。

目次

第1章 世界の酸化ストレスアッセイ市場の調査手法と範囲

  • 調査手法
  • 調査の目的と調査範囲

第2章 世界の酸化ストレスアッセイ市場-市場の定義と概要

第3章 世界の酸化ストレスアッセイ市場-エグゼクティブサマリー

  • 市場の内訳:製品別
  • 市場の内訳:検査タイプ別
  • 市場の内訳:技術別
  • 市場の内訳:疾患タイプ別
  • 市場の内訳:エンドユーザー別
  • 市場の内訳:地域別

第4章 世界の酸化ストレスアッセイ市場-市場力学

  • 市場に影響を与える要因
    • 促進要因
    • 抑制要因
    • 市場機会
    • 影響分析

第5章 世界の酸化ストレスアッセイ市場-業界分析

  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • アンメットニーズ

第6章 世界の酸化ストレスアッセイ市場-COVID-19分析

  • 市場のCOVID-19分析
    • COVID-19以前の市場シナリオ
    • 現在のCOVID-19の市場シナリオ
    • COVID-19以後の市場シナリオ/将来の市場シナリオ
  • COVID-19における価格の力学
  • 需要と供給のスペクトル
  • パンデミック時の市場に関連する政府のイニシアチブ
  • メーカーの戦略的イニシアチブ
  • 結論

第7章 世界の酸化ストレスアッセイ市場:製品別

  • イントロダクション
    • 市場規模分析、および前年比成長分析(%):製品別
    • 市場魅力指数:製品別
  • 消耗品*
    • イントロダクション
    • 市場規模分析、100万米ドル(2019年~2028年)、および前年比成長分析(%)(2020年~2028年)
  • 装置
  • キット
  • サービス

第8章 世界の酸化ストレスアッセイ市場:検査タイプ別

  • イントロダクション
    • 市場規模分析、および前年比成長分析(%):検査タイプ別
    • 市場魅力指数:検査タイプ別
  • 間接アッセイ*
    • イントロダクション
    • 市場規模分析、100万米ドル(2019年~2028年)、および前年比成長分析(%)(2020年~2028年)
  • 抗酸化能アッセイ
  • 酵素ベースのアッセイ
  • 活性酸素種(ROS)ベースのアッセイ

第9章 世界の酸化ストレスアッセイ市場:技術別

  • イントロダクション
    • 市場規模分析、および前年比成長分析(%):技術別
    • 市場魅力指数:技術別
  • 酵素免疫測定法(ELISA)*
    • イントロダクション
    • 市場規模分析、100万米ドル(2019年~2028年)、および前年比成長分析(%)(2020年~2028年)
  • クロマトグラフィー
  • フローサイトメトリー
  • 顕微鏡検査
  • ハイコンテントスクリーニング
  • ラベルフリー検出技術

第10章 世界の酸化ストレスアッセイ市場:疾患タイプ別

  • イントロダクション
    • 市場規模分析、および前年比成長分析(%):疾患タイプ別
    • 市場魅力指数:疾患タイプ別
  • 循環器疾患*
    • イントロダクション
    • 市場規模分析、100万米ドル(2019年~2028年)、および前年比成長分析(%)(2020年~2028年)
  • 糖尿病
  • 慢性閉塞性肺疾患(COPD)
  • 喘息

第11章 世界の酸化ストレスアッセイ市場:エンドユーザー別

  • イントロダクション
    • 市場規模分析、および前年比成長分析(%):エンドユーザー別
    • 市場魅力指数:エンドユーザー別
  • 製薬企業およびバイオテクノロジー企業*
    • イントロダクション
    • 市場規模分析、100万米ドル(2019年~2028年)、および前年比成長分析(%)(2020年~2028年)
  • 臨床ラボ
  • 学術機関・研究機関
  • 受託研究機関
  • その他

第12章 世界の酸化ストレスアッセイ市場:地域別

  • イントロダクション
    • 市場規模分析、100万米ドル(2019年~2028年)、および前年比成長分析(%)(2020年~2028年):地域別
    • 市場魅力指数:地域別
  • 北米
  • 欧州
  • 南米
  • アジア太平洋
  • 中東とアフリカ

第13章 世界の酸化ストレスアッセイ市場-競合情勢

  • 主な開発と戦略
  • 企業シェア分析
  • 製品のベンチマーク
  • 注目すべき主要企業のリスト

第14章 世界の酸化ストレスアッセイ市場-企業プロファイル概要

  • Abcam, plc.
    • 企業概要
    • 製品ポートフォリオおよび説明
    • 主要ハイライト
    • 財務概要
  • Enzo Biochem, Inc.
  • AMS Biotechnology Ltd.
  • BioVision, Inc.
  • Cell Biolabs, Inc.
  • Promega Corporation
  • Cayman Chemical
  • Eagle Biosciences, Inc.
  • Arbor Assays
  • Genox Corporation

第15章 世界の酸化ストレスアッセイ市場-DataM

  • 付録
  • 当社・アプリケーションについて
  • お問い合わせ
目次
Product Code: DMBT4826

Market Overview

Excess oxygen-derived free radicals within a cell or organism overpower the cell's or organism's innate antioxidant defences, resulting in oxidative stress. Proteins, lipids, and nucleic acids oxidize, leading to cancer, asthma, ischemia, diabetes, and cardiovascular and neurological illnesses. It is assessed using a variety of assays that aid healthcare professionals in better understanding the condition's processes and reactions.

The global oxidative stress assay market size was valued US$ XX million in 2020 and is estimated to reach US$ XX million by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

Market Dynamics

The development of a new fluorescent biosensor for measuring the redox status of metabolic methionine in cells and tissues in real-time is expected to drive market growth.

Trx1-cpYFP-fRMsr (TYfR), a genetically encoded fluorescence biosensor with exceptional specificity and sensitivity toward fMetRO (free Methionine-R-sulfoxide), allowing dynamic assessment of physiological levels of fMetRO, a novel indication of ROS and methionine redox state in vitro and in vivo. TYfR enables real-time and steady-state measurement of fMetRO from cells to whole-body level. Moreover, a thorough biochemical evaluation of the TYfR sensor demonstrated exceptional specificity and sensitivity, enabling both steady-state and real-time detection of physiological fMetRO concentrations in cells to whole-body levels. More notably, we discovered a considerable increase in fMetRO levels in human serum samples from patients with the acute coronary syndrome (ACS), one of the most serious ROS-related human diseases that becomes more apparent following the percutaneous coronary intervention utilizing the TYfR. (PCI). As a result of these findings, we believe our innovative platform has the potential to be used as a diagnostic tool for dynamic monitoring of ROS and methionine redox status, which indicates tissue damage buildup in ROS-related human illnesses. Thus, the market is expected to drive in the forecast period.

Restraint:

The high cost of instruments, shortage of skilled personnel for new and upcoming technologies and lack of awareness among the people are some of the factors that the market is expected to hamper the market growth.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. The infection induces pathological responses, including increased inflammation, oxidative stress, and apoptosis. This situation results in impaired gas exchange, hypoxia, and other sequelae that lead to multisystem organ failure and death. Oxidative stress is a physiological state in which the cellular antioxidant buffering capability is overwhelmed by systemic quantities of reactive oxygen species (ROS), eventually causing damage to cellular macromolecules. During normal cellular metabolism, ROS and free radicals are produced. ROS plays a favorable role in crucial signaling pathways required for essential cellular processes under normal physiological settings. Moreover, the pandemic interrupted the medical supply chain, and many companies will vary to other geographic regions in the future to ensure that products remain available and protect their supply chain. However, the situation is expected to improve gradually in the forecast period.

Segment Analysis

Indirect Assays segment is expected to hold the largest market share in oxidative stress assay market

The indirect assays segment is expected to dominate in 2020. The segment benefits because of its short lifespan and fast reactivity with redox status regulatory components; it is difficult to monitor ROS levels with high accuracy and precision directly. While peroxyl radicals and hydrogen peroxide have relatively long half-lives (seconds to minutes), hydroxyl radicals are extremely reactive (half-lives of less than a millisecond). As a result, assessing oxidative stress in clinical samples via indirect detection of ROS by studying the oxidative damage these radicals cause to the cells' lipids, proteins, and nucleic acids is a viable alternative approach. Thus, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global oxidative stress assay market

In 2020, North America accounted for the highest revenue share. The increasing prevalence of cancer, rising geriatric population, technological advancement in the devices, well-established infrastructure and product launches, acquisition and collaborations by the market players are some factors due to which the market is expected to boost in the forecast period. For instance, cancer is a major public health problem worldwide and is the second leading cause of death in the United States. According to the American Cancer Society, In 2021, 1.9 million new cancer cases will be diagnosed, and 608,570 cancer deaths in the United States. Moreover, The risk of developing cancer increases with advancing age; 80% of all cancers in the United States are diagnosed in people 55 years of age or older. Certain behaviors and other modifiable factors also increase risk, such as smoking, having excess body weight, drinking alcohol, and having an unhealthy diet. In the US, an estimated 41 out of 100 men and 39 out of 100 women will develop cancer during their lifetime. However, these probabilities are based on cancer occurrence in the general population and may differ because of variations in individual exposures (e.g., smoking), family history, or genetic susceptibility.

Additionally, Thermo Fisher Scientific Inc. and PPD announced on April 15, 2021, that their boards of directors had authorized a formal deal under which Thermo Fisher will acquire PPD for $47.50 per share in cash, plus the assumption of roughly $3.5 billion in net debt. Thermo Fisher purchased PPD to expand into clinical research services. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the oxidative stress assay market are Abcam, plc., Enzo Biochem, Inc., AMS Biotechnology Ltd., BioVision, Inc., Cell Biolabs, Inc., Promega Corporation, Cayman Chemical, Eagle Biosciences, Inc., Arbor Assays and Genox Corporation.

Arbor Assays:

Overview:

Arbor Assays specializes in developing high sensitivity assay kits, high-purity inhibitors, and antibodies for drug discovery and basic research. Products for research in non-invasive endocrinology, mitochondrial dysfunction, oxidative stress, cell signaling biomarkers, kidney damage, cholinesterase activity, and other areas are readily available. Moreover, it also offers custom assay development and testing services. We make unique kits to measure cGAMP, P450, AChE and BChE activity.

Product Portfolio:

DetectX Catalase Activity: The DetectX Catalase Activity Kit is designed to quantitatively measure catalase activity in a variety of samples.

Why Purchase the Report?

Visualize the composition of the oxidative stress assay market segmentation by product, test type, technology, disease type, end user and region highlighting the key commercial assets and players.

Identify commercial opportunities in oxidative stress assay market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of oxidative stress assay market- level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global oxidative stress assay market report would provide an access to an approx. 45+market data table, 40+figures and 170 pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Market Segmentation

Global Oxidative Stress Assay Market - By Product

Consumables

Instruments

Kits

Services

Global Oxidative Stress Assay Market - By Test Type

Indirect Assays

Antioxidant Capacity Assays

Enzyme-based Assays

Reactive Oxygen Species (ROS)-based Assays

Global Oxidative Stress Assay Market - By Technology

Enzyme-linked Immunosorbent Assay (ELISA)

Chromatography

Flow Cytometry

Microscopy

High-Content Screening

Label-free Detection Technology

Global Oxidative Stress Assay Market - By Disease Type

Cardiovascular Disease

Diabetes

Chronic Obstructive Pulmonary Disease (COPD)

Cancer

Asthma

Global Oxidative Stress Assay Market - By End user

Pharmaceutical and Biotechnology Companies

Clinical Laboratories

Academic Research Institutes

Contract Research Organizations

Others

Global Oxidative Stress Assay Market - By Region

North America

South America

Europe

Asia

Middle East & Africa

Table of Contents

1. Global Oxidative Stress Assay Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Oxidative Stress Assay Market - Market Definition and Overview

3. Global Oxidative Stress Assay Market - Executive Summary

  • 3.1. Market Snippet by Product
  • 3.2. Market Snippet by Test Type
  • 3.3. Market Snippet by Technology
  • 3.4. Market Snippet by Disease Type
  • 3.5. Market Snippet by End User
  • 3.6. Market Snippet by Region

4. Global Oxidative Stress Assay Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The development of a new fluorescent biosensor for measuring the redox status of metabolic methionine in cells and tissues in real-time is expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. Lack of awareness among the people is expected to hamper market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Oxidative Stress Assay Market - Industry Analysis

  • 5.1. Supply Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Regulatory Analysis
  • 5.4. Unmet Needs

6. Global Oxidative Stress Assay Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Oxidative Stress Assay Market - By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product Segment
  • 7.2. Consumables*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Instruments
  • 7.4. Kits
  • 7.5. Services

8. Global Oxidative Stress Assay Market - By Test Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 8.1.2. Market Attractiveness Index, By Test Type Segment
  • 8.2. Indirect Assays*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Antioxidant Capacity Assays
  • 8.4. Enzyme-based Assays
  • 8.5. Reactive Oxygen Species (ROS)-based Assays

9. Global Oxidative Stress Assay Market - By Technology

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 9.1.2. Market Attractiveness Index, By Technology Segment
  • 9.2. Enzyme-linked Immunosorbent Assay (ELISA)*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 9.3. Chromatography
  • 9.4. Flow Cytometry
  • 9.5. Microscopy
  • 9.6. High-Content Screening
  • 9.7. Label-free Detection Technology

10. Global Oxidative Stress Assay Market - By Disease Type

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
    • 10.1.2. Market Attractiveness Index, By Disease Type Segment
  • 10.2. Cardiovascular Disease*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 10.3. Diabetes
  • 10.4. Chronic Obstructive Pulmonary Disease (COPD)
  • 10.5. Cancer
  • 10.6. Asthma¬¬¬¬¬

11. Global Oxidative Stress Assay Market - By End user

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.1.2. Market Attractiveness Index, By End user Segment
  • 11.2. Pharmaceutical and Biotechnology Companies*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 11.3. Clinical Laboratorie¬¬¬¬s
  • 11.4. Academic Research Institutes
  • 11.5. Contract Research Organizations
  • 11.6. Others

12. Global Oxidative Stress Assay Market - By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
    • 12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 12.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
    • 12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 12.3.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. U.K.
      • 12.3.8.3. France
      • 12.3.8.4. Italy
      • 12.3.8.5. Spain
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
    • 12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. Brazil
      • 12.4.8.2. Argentina
      • 12.4.8.3. Rest of South America
  • 12.5. Asia Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
    • 12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. China
      • 12.5.8.2. India
      • 12.5.8.3. Japan
      • 12.5.8.4. Australia
      • 12.5.8.5. Rest of Asia Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
    • 12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

13. Global Oxidative Stress Assay Market - Competitive Landscape

  • 13.1. Key Developments and Strategies
  • 13.2. Company Share Analysis
  • 13.3. Product Benchmarking
  • 13.4. List of Key Companies to Watch

14. Global Oxidative Stress Assay Market- Company Profiles

  • 14.1. Abcam, plc.
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Key Highlights
    • 14.1.4. Financial Overview
  • 14.2. Enzo Biochem, Inc.
  • 14.3. AMS Biotechnology Ltd.
  • 14.4. BioVision, Inc.
  • 14.5. Cell Biolabs, Inc.
  • 14.6. Promega Corporation
  • 14.7. Cayman Chemical
  • 14.8. Eagle Biosciences, Inc.
  • 14.9. Arbor Assays
  • 14.10. Genox Corporation

LIST NOT EXHAUSTIVE

15. Global Oxidative Stress Assay Market - DataM

  • 15.1. Appendix
  • 15.2. About Us and Applications
  • 15.3. Contact Us